| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-08 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-07 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-07 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |